Preconditioning and the oxidants of sudden death

Current Opinion in Critical Care

Volumn 9, Issue 3, 2003, Pages 194-198

  Anderson, Travis ^a   Vanden Hoek, Terry L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cardiac arrest; Ischemia reperfusion injury; Oxidants; Preconditioning

Indexed keywords

ANTIOXIDANT; CARIPORIDE; ISOFLURANE; MORPHINE; NALOXONE; OPIATE DERIVATIVE; OXIDIZING AGENT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TEMPOL;

APOPTOSIS; DEFIBRILLATION; DRUG EFFECT; GAP JUNCTION; HEART ARREST; HEART INFARCTION PREVENTION; HUMAN; MULTIPLE ORGAN FAILURE; NONHUMAN; REPERFUSION INJURY; RESUSCITATION; REVIEW; SUDDEN DEATH; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANESTHETICS, INHALATION; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTIOXIDANTS; CARDIOPULMONARY RESUSCITATION; CASPASES; DEATH, SUDDEN, CARDIAC; ELECTRIC COUNTERSHOCK; GUANIDINES; HEART ARREST; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MODELS, ANIMAL; NARCOTICS; OXIDANTS; OXIDATIVE STRESS; SULFONES;

EID: 0038542817     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200306000-00004     Document Type: Review

References (40)

1. Vanden Hoek TL, Becker LB, et al.: Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998, 273:18092-18098.
2. Vanden Hoek TL, Becker LB, Shao Z, et al.: Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 2000, 86:534-540.
3. Vanden Hoek TL, Li C, Shao Z, et al.: Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 1997, 29:2571-2583.
4. Becker LB, Vanden Hoek TL, Shao Z, et al.: Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol 1999, 277:H2240-H2246.
5. Kevin LG, Camara AK, Riess ML, et al.: Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol 2003, 284:H566-H574. Preconditioning attenuates superoxide generation (as measured by dihydroethidine oxidation) during ischemia before and after reperfusion in an isolated heart model. This study suggests that significant oxidant stress is generated within minutes of global cardiac ischemia, as occurs during cardiac arrest.
6. Seaberg DC, Menegazzi JJ, Check B, et al.: Use of a cardiocerebral-protective drug cocktail prior to countershock in a porcine model of prolonged ventricular fibrillation. Resuscitation 2001, 51:301-308. Results showed that combination drug therapy before countershock produced far superior rates of ROSC and 1-hour survival compared with single-drug therapy and standard advanced care life support protocols. This was a porcine model of prolonged ventricular fibrillation. Interestingly, antioxidants were a major component of this cocktail and suggest a potential role of ROS in electrical arrhythmias and defibrillation thresholds.
7. Chakraborti T, Mandal A, Mandal M, et al.: Complement activation in heart diseases. Role of oxidants. Cell Signal 2000, 12:607-617.
8. Bottiger BW, Motsch J, Braun V, et al.: Marked activation of complement and leukocytes and an increase in the concentrations of soluble endothelial adhesion molecules during cardiopulmonary resuscitation and early reperfusion after cardiac arrest in humans. Crit Care Med 2002, 30:2473-2480. Cardiac arrest patients demonstrated increases in serum indices of complement and polymorphonuclear leukocyte activation. Of note, these increases occurred within minutes of cardiac arrest before defibrillation, and lower levels of these markers (associated with oxidant stress) were correlated with improved ROSC.
9. Wu ZK, Iivainen T, Pehkonen E, et al.: Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization. Circulation 2002, 106:3091-3096. Ventricular fibrillation and ventricular tachycardia are potentially life-threatening complications of coronary bypass. This study shows that preconditioning significantly reduced postoperative ventricular fibrillation/ventricular tachycardia in patients who underwent coronary artery bypass graft. Ventricular tachycardia during early reperfusion and 24 hours after reperfusion was suppressed and is suggestive of both the first and second windows of protection. This is one of the largest clinical studies of preconditioning.
10. Garcia-Dorado D, Ruiz-Meana M, Padilla F, et al.: Gap junction-mediated intercellular communication in ischemic preconditioning. Cardiovasc Res 2002, 55:456-465.
11. Gutstein DE, Morley GE, Tamaddon H, et al.: Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 2001, 88:333-339. In the context of other studies that suggest that connexin43 is an important target of preconditioning, this study is important in that it shows that a cardiac-restricted knockout of connexin43 (an integral protein in cardiac gap junctions) is associated with episodes of sudden death in mice. Modifications by preconditioning of connexin43 may provide important insights into antiarrhythmic effects.
12. Liu F, Gutstein DE: The cardiac gap junction: a potential therapeutic target in the treatment of heart disease. Mt Sinai J Med 2002, 69:421-424.
13. Ping P, Zhang J, Pierce WM, Jr., Bolli R: Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res 2001, 88:59-62. This study highlights the use of proteomics to elaborate targets of a protein kinase isoform involved in mediating preconditioning protection and as an important tool for studying the multiple targets of preconditioning.
14. Baines CP, Zhang J, Wang GW, et al.: Mitochondrial PKCepsilon and MAPK form signaling modules in the routine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res 2002, 90:390-397.
15. Gross GJ: The role of mitochondrial K(ATP) channels in the antiarrhythmic effects of ischaemic preconditioning in dogs. Br J Pharmacol 2002, 137:939-940.
16. Wann SR, Sr., Weil MH, Sun S, Tang W, Pellis T: Pharmacologic defibrillation. Crit Care Med 2002, 30:S154-156.
17. Avkiran M, Gross G, Karmazyn M, et al.: Na+/H+ exchange in ischemia, reperfusion and preconditioning. Cardiovasc Res 2001, 50:162-166.
18. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346:549-556.
19. Bernard SA, Gray TW, Buist MD, et al.: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346:557-563.
20. Weisfeldt ML, Becker LB: Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA 2002, 288:3035-3038.
21. Bottiger BW, Padosch SA, Wenzel V: Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002, 347:1281-1282.
22. Liu Y, Rosenthal RE, Haywood Y, et al.: Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids and improves neurological outcome. Stroke 1998, 29:1679-1686.
23. Zwemer CF, Whitesall SE, D'Alecy LG: Cardiopulmonary-cerebral resuscitation with 100% oxygen exacerbates neurological dysfunction following nine minutes of normothermic cardiac arrest in dogs. Resuscitation 1994, 27:159-170.
24. Behringer W, Safar P, Kentner R, et al.: Antioxidant Tempol enhances hypothermic cerebral preservation during prolonged cardiac arrest in dogs. J Cereb Blood Flow Metab 2002, 22:105-117.
25. Weil MH, Becker LB, Budinger T, et al.: Workshop executive summary report: post-resuscitative and initial utility in life saving efforts (PULSE). Circulation 2001, 103:1182-1184.
26. Hoshida S, Yamashita N, Otsu K, et al.: The importance of manganese superoxide dismutase in delayed preconditioning: involvement of reactive oxygen species and cytokines. Cardiovasc Res 2002, 55:495-505.
27. Bolli R: The late phase of preconditioning. Circ Res 2000, 87:972-983.
28. Andoh T, Chock PB, Chiueh CC: The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J Biol Chem 2002, 277:9655-9660.
29. Vanden Hoek TL, Qin Y, Wojcik K, et al.: Reperfusion, not simulated ischemia, initiates intrinsic apoptosis injury in chick cardiomyocytes. Am J Physiol 2003, 284:H141-H150. This study suggests that the postresuscitation phase after global ischemia in heart cells is associated with rapid cytochrome c release and the initiation of apoptosis. Antioxidants in this model attenuated cytochrome c release.
30. Jover T, Tanaka H, Calderone A, et al.: Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J Neurosci 2002, 22:2115-2124.
31. McLaughlin B, Hartnett KA, Erhardt JA, et al.: Caspase 3 activation is essential for neuroprotection in preconditioning. Proc Natl Acad Sci U S A 2003, 100:715-720. This is a neuronal preconditioning study that suggests that preconditioning affects the events associated with programmed cell death in surprising ways and highlights the importance of studying multiple targets of preconditioning and not just individual targets.
32. Adrain C, Martin SJ: The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 2001, 26:390-397.
33. Chen M, Won DJ, Krajewski S, et al.: Calpain and mitochondria in ischemia/reperfusion injury. J Biol Chem 2002, 277:29181-29186. This study shows that an inhibitor of the NHE prevents the activation of calpain after reperfusion, suggesting another possible mechanism of protection for NHE inhibitors. Proton accumulation during ischemia is corrected by the NHE, whereby the sodium-calcium exchange leads to a build up of calcium and subsequent activation of calpain. Calpain mediates mitochondrial dysfunction, release of proapoptotic factors, and cell death. In the context of other studies suggesting that NHE is a target for preconditioning and its inhibition can improve outcome in cardiac arrest, this study explores important consequences of NHE inhibitor protection.
34. Babsky A, Hekmatyar S, Wehrli S, et al.: Influence of ischemic preconditioning on intracellular sodium, pH, and cellular energy status in isolated perfused heart. Exp Biol Med (Maywood) 2002, 227:520-528.
35. Tanaka K, Weihrauch D, Kehl F, et al.: Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 2002, 97:1485-1490. The results of this study implicate the generation of nonlethal levels of ROS as the triggering mechanism of volatile anesthetic-induced protection. When the antioxidants N-2-mercaptopropionyl glycine and N-acetylcysteine were coadministered with isoflurane, they abolished the infarct-sparing effect of the anesthetic. This study demonstrates a possible means of triggering preconditioning protection via a volatile anesthetic.
36. Toller WG, Kersten JR, Gross ER, et al.: Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology 2000, 92:1400-1407.
37. Kohro S, Hogan QH, Nakae Y, et al.: Repeated or prolonged isoflurane exposure reduces mitochondrial oxidizing effects. Anesthesiology 2003, 98:275-278.
38. Schultz JE, Rose E, Yao Z, et al.: Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995, 268:H2157-H2161.
39. Fryer RM, Auchampach JA, Gross GJ: Therapeutic receptor targets of ischemic preconditioning. Cardiovasc Res 2002, 55:520-525.
40. Horton ND, Kaftani DJ, Bruce DS, et al.: Isolation and partial characterization of an opioid-like 88 kDa hibernation-related protein. Comp Biochem Physiol B Biochem Mol Biol 1998, 119:787-805.